BACKGROUND: The use of remote follow-up (RF) of people with pacemakers (PM) is limited in comparison to the hospital modality (HS), being still poor the scientific evidence that shows their comparative effectiveness. The aim of this study was to compare the quality of life in individuals with different modalities of follow-up. METHODS: Controlled, not randomized nor masked clinical trial, with data collection at pre and post-implantation of pacemakers during the 6 months follow-up. All patients over 18 years-old who were implanted a PM during the study period were selected (n = 83), and they were assigned to RF (n = 30) or HF (n = 53) groups according to their personal characteristics and patient's preferences. Baseline characteristics and number of visits to the hospital were analysed, the EuroQol-5D (EQ5D) questionnaire was administered to evaluate the health-related quality of life, and Duke Activity Status Index (DASI) to assess the functional capacity. RESULTS: There were no significant differences between both groups in relation to the baseline analysis, EQ5D (RF:0.7299; HF:0.6769) and DASI (RF:21.41; HF:19.99). At 6 months the quality of life was improved in both groups (EQ5D RF:0.8613; HF:0.8175; p = 0,439) still without significant differences between them. DASI score was similar to baseline (20.51 vs 21.80). RF group performed less transmissions/visits per patient (1.57) than hospital group (1.96; relative reduction 31%; p = 0.015). CONCLUSIONS: Remote follow-up of people with pacemakers might be considered as an equivalent option to the hospital follow-up in relation to the quality of life and it reduces the number of hospital visits.
RCT Entities:
BACKGROUND: The use of remote follow-up (RF) of people with pacemakers (PM) is limited in comparison to the hospital modality (HS), being still poor the scientific evidence that shows their comparative effectiveness. The aim of this study was to compare the quality of life in individuals with different modalities of follow-up. METHODS: Controlled, not randomized nor masked clinical trial, with data collection at pre and post-implantation of pacemakers during the 6 months follow-up. All patients over 18 years-old who were implanted a PM during the study period were selected (n = 83), and they were assigned to RF (n = 30) or HF (n = 53) groups according to their personal characteristics and patient's preferences. Baseline characteristics and number of visits to the hospital were analysed, the EuroQol-5D (EQ5D) questionnaire was administered to evaluate the health-related quality of life, and Duke Activity Status Index (DASI) to assess the functional capacity. RESULTS: There were no significant differences between both groups in relation to the baseline analysis, EQ5D (RF:0.7299; HF:0.6769) and DASI (RF:21.41; HF:19.99). At 6 months the quality of life was improved in both groups (EQ5D RF:0.8613; HF:0.8175; p = 0,439) still without significant differences between them. DASI score was similar to baseline (20.51 vs 21.80). RF group performed less transmissions/visits per patient (1.57) than hospital group (1.96; relative reduction 31%; p = 0.015). CONCLUSIONS: Remote follow-up of people with pacemakers might be considered as an equivalent option to the hospital follow-up in relation to the quality of life and it reduces the number of hospital visits.
Authors: Antonio López-Villegas; Daniel Catalán-Matamoros; Emilio Robles-Musso; Salvador Peiró Journal: Clin Res Cardiol Date: 2015-09-30 Impact factor: 5.460
Authors: Remedios López-Liria; Antonio López-Villegas; Terje Enebakk; Hilde Thunhaug; Knut Tore Lappegård; Daniel Catalán-Matamoros Journal: Int J Environ Res Public Health Date: 2019-06-05 Impact factor: 3.390
Authors: Remedios López-Liria; Antonio López-Villegas; César Leal-Costa; Salvador Peiró; Emilio Robles-Musso; Rafael Bautista-Mesa; Patricia Rocamora-Pérez; Knut Tore Lappegård; Daniel Catalán-Matamoros Journal: Int J Environ Res Public Health Date: 2020-02-23 Impact factor: 3.390
Authors: Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Salvador Peiro; Knut Tore Lappegard; Remedios Lopez-Liria Journal: PLoS One Date: 2020-01-29 Impact factor: 3.240
Authors: Antonio Lopez-Villegas; César Leal-Costa; Mercedes Perez-Heredia; Irene Villegas-Tripiana; Daniel Catalán-Matamoros Journal: Int J Environ Res Public Health Date: 2021-11-18 Impact factor: 3.390
Authors: Rafael Jesus Bautista-Mesa; Antonio Lopez-Villegas; Salvador Peiro; Daniel Catalan-Matamoros; Emilio Robles-Musso; Remedios Lopez-Liria; Cesar Leal-Costa Journal: BMC Geriatr Date: 2020-11-16 Impact factor: 3.921
Authors: Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Knut Tore Lappegård; Remedios Lopez-Liria Journal: Int J Environ Res Public Health Date: 2020-10-21 Impact factor: 3.390
Authors: Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Cesar Leal Costa; Rafael Bautista-Mesa; Emilio Robles-Musso; Patricia Rocamora Perez; Remedios Lopez-Liria Journal: PLoS One Date: 2021-12-23 Impact factor: 3.240